Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $5,237 | 2 | 88.6% |
| Food and Beverage | $582.49 | 22 | 9.9% |
| Education | $89.99 | 1 | 1.5% |
| Unspecified | $0 | 5 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Innovative Medical Technologies, LLC | $5,237 | 7 | $0 (2021) |
| Astellas Pharma US Inc | $246.73 | 6 | $0 (2019) |
| Boston Scientific Corporation | $149.95 | 4 | $0 (2024) |
| Medtronic USA, Inc. | $91.82 | 2 | $0 (2017) |
| Janssen Biotech, Inc. | $46.11 | 3 | $0 (2019) |
| Olympus America Inc. | $31.34 | 1 | $0 (2022) |
| Axonics, Inc. | $24.60 | 1 | $0 (2023) |
| AbbVie, Inc. | $22.90 | 2 | $0 (2017) |
| BAXTER HEALTHCARE | $17.10 | 1 | $0 (2019) |
| PFIZER INC. | $15.85 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85.08 | 1 | Boston Scientific Corporation ($85.08) |
| 2023 | $24.60 | 1 | Axonics, Inc. ($24.60) |
| 2022 | $31.34 | 1 | Olympus America Inc. ($31.34) |
| 2021 | $0 | 1 | Innovative Medical Technologies, LLC |
| 2020 | $0 | 1 | Innovative Medical Technologies, LLC |
| 2019 | $225.83 | 10 | Astellas Pharma US Inc ($130.24) |
| 2018 | $45.16 | 4 | Astellas Pharma US Inc ($18.54) |
| 2017 | $5,497 | 11 | Innovative Medical Technologies, LLC ($5,237) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Boston Scientific Corporation | Lumenis Pulse 120H (Device) | Food and Beverage | In-kind items and services | $85.08 | General |
| Category: Lumenis Pulse 120H_URO | ||||||
| 06/14/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Urology | ||||||
| 02/28/2022 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $31.34 | General |
| Category: Urology Gynecology | ||||||
| 2021 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 2020 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 09/12/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: Oncology | ||||||
| 09/04/2019 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Diagnostic Imaging | ||||||
| 08/12/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2019 | Boston Scientific Corporation | LITHOVUE (Device) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: SCOPE | ||||||
| 06/04/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.99 | General |
| 05/15/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: ONCOLOGY | ||||||
| 04/10/2019 | BAXTER HEALTHCARE | FLOSEAL (Biological) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Surgical Care | ||||||
| 03/06/2019 | Boston Scientific Corporation | GREENLIGHT (Device) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: PROSTATE HEALTH | ||||||
| 01/30/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: UROLOGY | ||||||
| 2019 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 10/03/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2018 | PFIZER INC. | SUTENT (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 05/21/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL KIDNEY STONE DISEASE (Device) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: KIDNEY STONE DISEASE | ||||||
| 2018 | Innovative Medical Technologies, LLC | — | — | — | $0.00 | Ownership |
| 12/19/2017 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $79.37 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/21/2017 | AbbVie, Inc. | Androgel (Drug), Lupron | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Endocrinology | ||||||
| 09/19/2017 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $97.95 | General |
| 08/28/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Oncology | ||||||
| 07/17/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Oncology | ||||||
| 06/13/2017 | Retrophin, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Kidney Stones | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 479 | 538 | $182,337 | $34,019 |
| 2022 | 9 | 588 | 659 | $193,613 | $38,425 |
| 2021 | 10 | 635 | 774 | $229,658 | $54,231 |
| 2020 | 9 | 547 | 663 | $209,919 | $39,439 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 135 | 177 | $51,153 | $11,592 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 111 | 122 | $24,888 | $5,141 | 20.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 40 | 42 | $13,146 | $3,762 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $15,135 | $3,686 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 42 | 42 | $15,750 | $3,346 | 21.2% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 20 | 21 | $32,006 | $2,457 | 7.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $3,758 | $1,062 | 28.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 19 | 19 | $15,998 | $1,001 | 6.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 16 | 16 | $4,146 | $899.70 | 21.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 27 | 29 | $3,682 | $582.13 | 15.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 26 | 27 | $2,675 | $490.62 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 125 | 150 | $39,693 | $9,954 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 171 | 208 | $37,573 | $8,928 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 103 | 103 | $37,581 | $8,584 | 22.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 37 | 41 | $12,300 | $4,037 | 32.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 44 | 46 | $34,301 | $2,661 | 7.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 36 | 36 | $8,798 | $1,771 | 20.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 12 | 12 | $17,244 | $1,176 | 6.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 37 | 40 | $3,463 | $773.62 | 22.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 23 | 23 | $2,660 | $539.53 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 162 | 243 | $57,348 | $16,425 | 28.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 128 | 128 | $45,696 | $11,618 | 25.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 160 | 203 | $32,683 | $10,110 | 30.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 40 | 44 | $13,200 | $4,583 | 34.7% |
| 52356 | Crushing of stone in urinary duct (ureter) with stent using an endoscope | Facility | 2021 | 12 | 14 | $20,104 | $4,321 | 21.5% |
About Dr. John Richier, MD
Dr. John Richier, MD is a Specialist healthcare provider based in Tullahoma, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437116324.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Richier, MD has received a total of $5,909 in payments from pharmaceutical and medical device companies, with $85.08 received in 2024. These payments were reported across 30 transactions from 12 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($5,237).
As a Medicare-enrolled provider, Richier has provided services to 2,249 Medicare beneficiaries, totaling 2,634 services with total Medicare billing of $166,114. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Urology
- Location Tullahoma, TN
- Active Since 04/26/2006
- Last Updated 10/13/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1437116324
Products in Payments
- INTERSTIM (Device) $91.82
- Lumenis Pulse 120H (Device) $85.08
- XTANDI (Drug) $47.25
- ZYTIGA (Drug) $35.13
- GREENLIGHT (Device) $31.80
- iTIND System (Device) $31.34
- Axonics (Device) $24.60
- Androgel (Drug) $22.90
- LITHOVUE (Device) $22.30
- FLOSEAL (Biological) $17.10
- SUTENT (Drug) $15.85
- Axumin (Drug) $13.41
- (815) Thiola (Drug) $12.67
- MYRBETRIQ (Drug) $11.54
- Erleada (Drug) $10.98
- GENERAL KIDNEY STONE DISEASE (Device) $10.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Tullahoma
Jeffrey Marvel, M.d, M.D
Specialist — Payments: $34,261
Dr. Suzanne Collier, Md, MD
Specialist — Payments: $1,082
William Milam, M.d, M.D
Specialist — Payments: $477.97
Byron Robison, Md, MD
Specialist — Payments: $164.69
Jan Crean, Md, MD
Specialist — Payments: $80.96
Patty Marvel, M.d, M.D
Specialist